SCHEMBL9434737

SCHEMBL9434737

O=C(C=Cc1cccc(C(=O)c2ccccc2)c1)Cc1cccnc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
LMNA P02545 2/20 0.52
THRB P10828 2/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
CYP1A2 P05177 7/20 0.50
CYP1A1 P04798 6/20 0.50
CYP1B1 Q16678 6/20 0.50
CYP3A4 P08684 6/20 0.50
CYP2D6 P10635 6/20 0.50
GRM2 Q14416 1/20 0.47
VNN1 O95497 1/20 0.47
NAPRT Q6XQN6 1/20 0.47
TBXAS1 P24557 2/20 0.46
APP P05067 1/20 0.45
GSK3B P49841 1/20 0.45
USP2 O75604 1/20 0.45
NAMPT P43490 1/20 0.45
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
HPGD P15428 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9434748 0.83 CYP1A1 (0.62) ALDH1A1LMNATHRBSMN1; SMN2CYP1A2
SCHEMBL9434440 0.81 LMNA (0.47) ALDH1A1LMNATHRBSMN1; SMN2CYP1A2
SCHEMBL9433864 0.81 NAPRT (0.47) ALDH1A1LMNATHRBSMN1; SMN2CYP1A2
SCHEMBL9434693 0.81 CYP1A2 (0.56) ALDH1A1LMNATHRBSMN1; SMN2CYP1A2
SCHEMBL9434664 0.81 ALDH1A1 (0.72) ALDH1A1LMNATHRBSMN1; SMN2CYP1A2
SCHEMBL9434590 0.79 P4HB (0.58) LMNATHRBVNN1NAMPTHTT
SCHEMBL9434552 0.79 P4HB (0.48) ALDH1A1LMNAVNN1NAPRTTBXAS1
SCHEMBL9434478 0.78 ALDH1A1 (0.57) ALDH1A1LMNATHRBSMN1; SMN2CYP1A2
SCHEMBL9433920 0.78 TBXAS1 (0.56) THRBCYP1A2CYP1A1CYP1B1CYP3A4
SCHEMBL7382581 0.78 TGM2 (0.66) ALDH1A1LMNASMN1; SMN2HPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5276150-A Vasodilators, anticoagulants, calcium channel blockers FUJIREBIO INC. (JP) 1994-01-04 US disclosed
EP-0400660-A1 1,4-dihydropyridine derivatives FUJIREBIO INC. (JP) 1990-12-05 EP disclosed